投資者關係新聞2020-10-27《神州民企》四环医药获准内地推肉毒毒素Preview上一篇四环医药：国内独家代理肉毒毒素乐提葆上市，千亿市场迎重磅玩家下一篇Sihuan Pharmaceutical receives approval for its exclusive medical aesthetic product Letybo (botulinum toxin), A blockbuster product in a hundred-billion size market
